- Home
- ATAI vs OSUR Comparison
ATAI vs OSUR Comparison
Compare ATAI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- OSUR
- Stock Information
- Founded
- ATAI 2018
- OSUR 2000
- Country
- ATAI Germany
- OSUR United States
- Employees
- ATAI N/A
- OSUR N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- ATAI Health Care
- OSUR Health Care
- Exchange
- ATAI Nasdaq
- OSUR Nasdaq
- Market Cap
- ATAI 282.6M
- OSUR 223.0M
- IPO Year
- ATAI 2021
- OSUR 1986
- Fundamental
- Price
- ATAI $1.41
- OSUR $2.60
- Analyst Decision
- ATAI Strong Buy
- OSUR Hold
- Analyst Count
- ATAI 3
- OSUR 2
- Target Price
- ATAI $10.50
- OSUR $5.50
- AVG Volume (30 Days)
- ATAI 1.4M
- OSUR 444.5K
- Earning Date
- ATAI 05-19-2025
- OSUR 05-07-2025
- Dividend Yield
- ATAI N/A
- OSUR N/A
- EPS Growth
- ATAI N/A
- OSUR N/A
- EPS
- ATAI N/A
- OSUR N/A
- Revenue
- ATAI $308,000.00
- OSUR $161,626,000.00
- Revenue This Year
- ATAI $65.58
- OSUR N/A
- Revenue Next Year
- ATAI N/A
- OSUR $7.55
- P/E Ratio
- ATAI N/A
- OSUR N/A
- Revenue Growth
- ATAI N/A
- OSUR N/A
- 52 Week Low
- ATAI $1.03
- OSUR $2.69
- 52 Week High
- ATAI $2.57
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- ATAI 44.57
- OSUR 30.12
- Support Level
- ATAI $1.36
- OSUR $2.91
- Resistance Level
- ATAI $1.54
- OSUR $3.09
- Average True Range (ATR)
- ATAI 0.09
- OSUR 0.11
- MACD
- ATAI -0.00
- OSUR -0.02
- Stochastic Oscillator
- ATAI 0.00
- OSUR 26.47
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.